OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

BEHÇET’S PATIENTS CENTRES (A charitable company limited by guarantee)

Annual Report and unaudited Financial Statements for the year from 1 April 2022 to 31 March 2023

Company No: 08085618

Charity No: 1148599

Behçet’s Patients Centres Annual Report 2023

1

BEHÇET’S PATIENTS CENTRES (A charitable company limited by guarantee)

Contents of the Financial Statements For the year ended 31 March 2023

A. Directors’ Report...................................................3 - 15
B. Directors’ Responsibilities.....................................16
C. Statement of Financial Activities 2023 …..……….17
Statement of Financial Activities 2022…….………18
D. Balance Sheet……………………………...………..19
E. Notes to the Financial Statements………..…….…20 - 22
F. Independent Examiner’s Report…………….……..23

Behçet’s Patients Centres Annual Report 2023

2

A. Directors’ Report

1. Reference and Administrative Information

Charitable Company Name: Behçet’s Patients Centres
Company No: 08085618
Charity No: 1148599
Registered Office c/o Critchleys LLP
23-38 Hythe Bridge Street
OXFORD
OX1 2EP
Administrative Address: 17 Culverley Crescent
Knowle
SOLIHULL
B93 9RB
Accountants: UHY Ross Brooke
Suite I, Windrush Court
Abingdon Business Park
ABINGDON
OX14 1SY
Members: Behçet's UK
Alan Lane
Jan Mather
Amanda Moseley
Mike Rawlins
Judith Scott
Directors: Jan Mather (Chair)
Mike Rawlins (Vice Chair)
Alan Lane (Secretary and Finance Director)
Amanda Moseley
Judith Scott
NHS Advisor: Prof. Farida Fortune
Commencement The Company was incorporated on 28 May 2012 and
commenced operations on 1 June 2012.

Behçet’s Patients Centres Annual Report 2023

3

2. Structure, Governance and Management

2.1 Governing Document: Memorandum and Articles of Association

The charitable company operates with a voluntary management committee/Board of Directors who meet on a bi-annual basis, with additional meetings via telephone conference as required.

Other members of the Board can be appointed by the existing Directors. In so doing they will have regard to the need for the Board to contain a range of skills and relevant experience and will ensure that newly appointed Directors are appropriately trained as to their legal responsibilities. The liability of the Directors is limited by guarantee.

The Directors are not entitled to and did not receive any remuneration during the period.

2.2 Annual General Meeting

The Annual General Meeting was held on 8 June 2022. During the meeting, Janet Mather and Judith Scott were re-appointed as Directors following the expiry of their terms of office.

2.3 Employees

The employees of the BPC have remained the same throughout this financial year.

John Mather - Operations Manager - employed February 2014

The Support Coordinators are:

Rebecca Hyder – Birmingham Centre of Excellence – employed March 2015 Jackie Pooler – Liverpool Centre of Excellence – employed July 2014 Jean Christians – London Centre of Excellence – employed March 2013.

3. Objectives, Activities, Achievements & Performance

Behçet’s UK (formerly Behçet’s Syndrome Society) undertook a survey of its membership during 2008 which revealed that Behçet’s is more debilitating than previously understood. The Quality-ofLife survey revealed that the impact of Behçet’s is like that of Multiple Sclerosis, which has an approved patient pathway through the NHS. With this, and the knowledge that on average it was taking 12 years for Behçet’s patients to receive a diagnosis, Behçet’s UK began an application to the National Specialised Commissioning Group for Centres of Excellence to be established to treat patients with Behçet’s.

The bid to establish the Centres of Excellence was successful and the Centres were established in April 2012. The Behçet’s Patients Centres charitable company was established in conjunction with Behçet’s UK to manage the NHS contract whilst ensuring the vision for patients was delivered.

Behçet’s Patients Centres (BPC) complements the national clinical service that NHS England commissions from three expert providers in England for patients with Behçet’s through the three Centres of Excellence located in London, Birmingham and Liverpool.

It supports the delivery of high-quality specialised care to patients who have this rare disease. It supports the services to ensure that patients with Behçet’s have coordinated care and are provided with full information about their condition.

The current Service Specification agreed with the NHS in 2020 for the period from April 2020 to March 2024 ensures that the non-medical support work carried out by Behçet’s Patients Centres, through the Support Coordinators and Operations Manager employed by the charity, is a true reflection of that work.

New ways of working (post COVID 19)

Each Centre has utilised technology with a mixture of face-to-face, video and telephone consultations, dependent on the availability of consultants and the requirements of patients.

Behçet’s Patients Centres Annual Report 2023

4

For the Support Coordinators, the preference is face-to-face consultations as so much of their work is based around these conversations and they help us provide the right level of non-medical support for our patients. Chatting and listening to patients is a key function of the role of the Support Coordinators. The Operational staff have adapted well to new ways of working with our colleagues in the NHS. They have maintained contact with patients whether that be face-to-face or virtually by video or telephone to check in with them and make them aware that the services of the charity are available to help with their non-medical needs.

The Support Coordinators have continued throughout the reporting period to demonstrate their flexibility to meet the non-medical support needs of their patients.

3.1 Description of Services as agreed with NHS England

Behçet’s Patients Centres Annual Report 2023

5

3.2 Achievements for Financial Year 2022-23 and performance in relation to objects and Service Agreement Outputs

Deliverables

Deliverables:

The statistics for the last 12 months (below) show the number of patients supported and the types of contact Support Coordinators have had with patients.

As previously highlighted, the pandemic has led to a hybrid way of working, with a mixture of faceto-face and virtual appointments. Although it is likely a hybrid model of working will continue to be implemented post pandemic, it’s not thought the contact will reflect previous years of predominantly being seen within the clinic; however, we will continue to work with the NHS clinical teams and our patients.

Behçet’s Patients Centres Annual Report 2023

6

The following data charts highlight the fluctuating nature of the role of the Support Coordinators, numbers continue to vary each quarter based upon a variety of factors:

Behçet’s Patients Centres Annual Report 2023

7

The Operations Manager has also analysed the database of patients to identify “Active” patients, where active is based upon some contact with a Support Coordinator in the previous two-year period.

This review of patients recognises the fluctuating nature of Behçet’s and is a truer measure of the number of patients being supported by BPC.

----- Start of picture text -----
Active
489
558 Birmingham Centre
Liverpool Centre
London Centre
317 1,364 Total
----- End of picture text -----

3.2.3 Fostering education, collaboration and networking in the medical and allied professions:

The BPS Matters newsletter continues to promote the Support Coordinators’ perspective of work within the clinic and is shared across the medical staff at all three Centres. As well as highlighting particularly interesting cases (which are anonymised), the newsletter also shares some of the key successes achieved with patients, any trends, positive or negative, with benefits, welfare or other agency support, plus how the charity and staff continue to support the NHS and Behçet’s UK.

3.2.4 The promotion and assistance of research into Behçet’s disease and the dissemination of the useful results:

The formation of the Centres will provide the largest sample population available in England to conduct research into Behçet’s disease. Each of the Centres is discussing potential research, how they can collaborate amongst themselves and with other medical professionals. We are also working closely with Behçet’s UK as they progress their ambition to develop a register of patients which will also assist with identifying the sample population.

Behçet’s Patients Centres Annual Report 2023

8

3.3 Service Agreement Outputs:

3.3.1 Patient Advocacy and engagement in service delivery

Following attendance at a clinic in a Centre of Excellence, patients are sent an anonymous electronic survey to complete to provide feedback on the service they received. These are closely monitored and reviewed to highlight areas for improvement or for sharing best practice amongst the Centres. The feedback is overwhelmingly positive and includes the following sample quotes:

Behçet’s Patients Centres Annual Report 2023

9

3.3.2 Dedicated Website

The website for Behçet’s Patients Centres (BPC) under the trading name of Behçet’s Patients Support is a resource actively promoted by the Support Coordinators .

The website can be found at https://behcetspatients.org.uk/. The website provides a “one-stop” for all information about the Centres of Excellence, with links to all three Centres and to Behçet’s UK to promote the “In partnership with the NHS and Behçet’s UK” mission of the charity.

The website provides specific information in the following areas:

Having a dedicated website allows for the charity to promote themes, for example links to the current Behçet’s Quality of Life Survey, information on the cost-of-living crisis and the qualitative feedback survey. When complete, the new sections dedicated to new patients and young people will help patients access the non-medical support they need.

3.3.3 Newsletter articles provided from both patients and clinic staff for publication in the quarterly Behçet’s UK newsletter.

Throughout 2022/23, the Centres have been represented with a significant presence in the Behçet’s UK newsletter. Each of the Centres is encouraged to provide articles for every edition with one of the Support Coordinators also providing information on lifestyle management and wellbeing. Articles this year have included:

Behçet’s Patients Centres Annual Report 2023

10

3.3.4 Patient Information Pack – ensuring all patients who attend clinic for the first time receive a copy.

A Patient Information Pack continues to be distributed by the Support Coordinators at the Centres.

Following feedback from patients attending a centre, patients were becoming overwhelmed by the breadth of areas the disease could potentially affect which was having a negative impact on their wellbeing at a time when they were coming to terms with a new diagnosis.

The information pack given at their first clinic visit therefore only includes factsheets on:

A digital version of our summary information pack is now also available for either downloading from our website (https://behcetspatients.org.uk/beh%C3%A7et%E2%80%99s-factsheets) or for email to a patient. We also encourage our patients to visit the website of Behçet’s UK (https://behcetsuk.org/behcets-medical-factsheets/) where the most up to date information sheets on all the symptoms of the illness can be viewed and downloaded.

The Support Coordinator will continue to facilitate the provision of information to ensure all patients have access to the most up to date and appropriate information in a format relevant to them.

3.3.5 Support Coordinator workload prioritisation should aim for 65% direct face to face contact with patients: 30% other contact / facilitation work and 5% raising awareness activities.

The Support Coordinators log their time against categories of work they undertake to ensure their workload prioritisation is aligned to the Company’s Service Agreement.

The job plan for the Support Coordinators is broken down as follows:

The statistics for the last 12 months are below:

Data shows the flexible approach adopted by the Support Coordinators in switching between face to face and other contact as the Covid-19 protocols allowed.

Behçet’s Patients Centres Annual Report 2023

11

3.3.6 Training and Development – contribute to the Behçet’s UK AGM to promote the service.

The charity attended the October AGM of Behçet’s UK. The presentation was given by the Operations Manager supported by the London Support Coordinator:

We are keen to know what went well on their visit / contact; what didn't go so well on their visit / contact; what could have been better and are there any specific changes or improvements they would like to see implemented?

3.3.7 Raising Awareness of Services Provision

The Commissioning for Quality and Innovation (CQUIN) framework supports improvements in the quality of services and the creation of new, improved patterns of care as appropriate.

The Operations Manager will present the achieved outcomes of the service provided by BPC at the annual NHS CQUIN Meeting which is due to be held in May 2023. The presentation will allow for the work of the BPC to be showcased to the National Commissioners and to share successes and the value added for the benefit of patients attending a Centre of Excellence with medical NHS colleagues.

3.3.8 Provide Stakeholder engagement by publishing a quarterly ‘BPS Matters’ to key

medical staff in clinics.

The ‘ BPS Matters’ newssheet has been produced quarterly during 2022/23 and circulated to the Lead Clinician of each Centre along with the NSCG Commissioner and the Chair of Behçet’s UK. The aim of this newssheet is to highlight to the medical team within the Centres any trends we are observing and to share best practice amongst the Centres. This publication continues to be well received with each of the Centre Leads circulating to their teams. A summary of the newssheet is published in the Behçet’s UK Quarterly newsletter as well as being made available on our website (https://behcetspatients.org.uk/bps-matters-newsletter)

Sections include:

3.4 Looking to 2023-24

3.4.1 Training

The service has become well established with feedback being overwhelmingly positive, however ways to improve the services to patients are always being sought.

All Support Coordinators have rolling NHS Honorary Contracts in place and with that comes the responsibility to complete all relevant mandatory training. Such training being provided by the relevant NHS Trust and online via “elearning for healthcare” (elfh is a Health Education England - programme in partnership with the NHS and professional bodies https://www.e lfh.org.uk/). Courses

Behçet’s Patients Centres Annual Report 2023

12

completed alongside the mandatory NHS modules include; Social Prescribing, Mindfulness, Physical Activity and Heath, Work and Health to name but a few.

The Company continues to look for appropriate courses to ensure our Support Coordinators remain current with any benefits changes as this is an ongoing need.

The personal development of the team is under consideration, after undertaking coaching training and resilience training in previous years.

The training will be agreed collaboratively based on need and timeliness together with the benefit it will deliver for our service users.

3.4.2 Meeting schedules

The BPC has held four Board meetings by video conference during financial year 2022-23. In addition, the BPC AGM was held on 8[th] June 2022 also via video conference.

During the financial year 2023-24, it is intended to revert to the model of two face-to-face meetings, generally in the Spring and Autumn. Each meeting will continue to be minuted to reflect the discussions and agreed actions.

In addition, a joint meeting using video conferencing was held between the BPC and Behçet’s UK to ensure we remain aligned, and our services are complimentary for the benefits of patients.

3.4.3 Company Training Day(s)

The BPC also held a face-to-face training meeting during financial year 2022-23, with the meeting being attended by all the operational staff and available Directors. The objectives of the meeting were to ensure the Directors were fully briefed on the variety of work that is undertaken by the Support Coordinators, to keep them up to date with trends and best practice and to focus on specific tools to assist in managing their workload and priorities.

This type of training will continue on an annual basis with any relevant learning and action points noted and shared via either BPS Matters or via the Behçet’s UK newsletter.

3.4.4 Quality of Life survey

A new, online version of the Quality-of-Life survey was created in collaboration with the three Centres of Excellence and Behçet’s UK.

The survey was conducted online to reduce costs and make the analysis easier, following its launch via the Behçet’s UK newsletter and the various social media accounts of Behçet’s UK, a total of 459 patients and members completed the survey.

This study analyses the 2020 survey and reviews the 2009, 2014 surveys to ascertain which Behçet’s symptoms, personal and family status, patients’ lifestyle, and work-related outcomes impacted on Health-Related Quality of Life (HRQoL).

Methods: 459 Behçet’s patients submitted an online survey/questionnaire. Patients provided information on socio-demographic characteristics, disease duration, historical and current symptoms, systemic and topical medication, health related lifestyle, work-related outcomes regarding employment status and claiming benefits and QoL measured by EQ-5D index.

Behçet’s Patients Centres Annual Report 2023

13

Conclusion: the main cause for the negative impact on BS patients QoL over the 10 years were joint pain and neurological problems.

In addition, sociodemographic (gender, age, marital and education status), lifestyle (medication, cannabis, drinking wine and regular exercise), employment status (employee and no career change), and accessing benefits (never claim benefit) all had a significant influence on patients’ HRQoL.

These results will continue to feed into our drive towards “Living well with Behçet’s” to ensure we provide support and information to enable patients to stay in education / employment and to stay as active as their health will allow.

3.4.5 Risks

The Board of Directors has considered the risks to which the charity is exposed.

The most significant risk is that the four-year contract agreed from April 2020 with an initial 7.6% uplift in funding and a further uplift of 3.8% from 1 April 2022 has not kept pace with inflation in salary and other costs..

The charity’s salaries have remained aligned with the cost of living increases awarded to NHS staff averaging around 5% a year, while non-staff costs are currently increasing at around 10% a year.

Representations were made by the Board in October 2022, requesting an uplift in the value of the contract from April 2023: whilst this request was denied, NHS England have indicated that an uplift from April 2024 is likely to be considered favourably.

Whereas the Company had an operating deficit in 2022-23 and is likely to have a larger one in 202324, its reserves are more than adequate to cope with this situation for at least the medium term.

The Directors are therefore of the opinion that the charity is a going concern.

Directors will also continue to monitor cash flow closely, as well as ensuring that any recruitment procedures include Disclosure Barring Service checks, that staff are appropriately trained and that there are relevant policies including a Data Protection policy that reflects the newly introduced data privacy regulations. Directors will continue to take out appropriate insurance for the services that the Company provides.

Behçet’s Patients Centres Annual Report 2023

14

4. Financial Review

The Company was incorporated on 28 May 2012. Its first financial period ended on 31 May 2013, after which the accounting reference date was changed to 31 March for subsequent years. This report relates to the financial year ending 31 March 2023.

The Company’s main source of income is a grant from the National Health Service Commissioning Board by means of a contract with the Company to provide support services to Behçet’s patients in conjunction with the three Patients Centres. Some additional income has been received from the Barts Health NHS Trust in order to extend the administrative support provided by one of the Support Co-ordinators at the London clinic and some small charitable donations have again been received this year.

The Company employs three Support Coordinators and finances their recruitment and training, the provision of laptop computers and stationery, including patient information packs, and meets the Support Coordinators’ travel costs and incidental expenses. In addition, the Company employs its own part-time Operations Manager and contributes to the costs of the Behçet’s UK newsletter.

At the end of the previous financial period, the Company had total reserves of £50.8k. In the period ending 31 March 2023 it received income of £117.4k, principally from NHS England, and spent some £118.6k on charitable activities and £2.8k on governance costs, giving a deficit of £4.1k for the period, which was funded from the reserves brought forward from earlier years.

4.1 Investment Policy

The Directors’ policy on finance is to utilise its CAF Bank current account for routine income and expenditure and to place funds not needed in the short term on deposit with a Scottish Widows 90day account. The BPC is responsible for delivering to the National Specialised Commissioning Groups award and therefore it is not anticipated that a large reserve will be created. Claims are made on a monthly basis to the NSCG to cover planned expenditure.

4.2 Reserves Policy

The Company's reserves at 31 March 2023 were £46.8k. Directors aim to maintain reserves at a level not exceeding the company’s normal income for a six-month period, together with any funds necessary to meet expenditure on activities that are incomplete at the end of a financial period, as a contingency in the event of the non-renewal of the contract with NHS England to provide for an orderly winding-up of the company's activities.

4.3 Basis of Preparation

The financial statements comply with the Charities Act 2011, the Companies Act 2006 and Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with FRS 102.

4.4 Public Benefit

The Directors have had regard to the Charity Commission’s guidance on public benefit, as detailed in section 3 above.

Behçet’s Patients Centres Annual Report 2023

15

B. Directors’ Responsibilities

The Directors are responsible for preparing the Directors’ Report and the financial statements in accordance with applicable law and regulations.

Company law requires the Directors to prepare financial statements for each financial year. Under that law, the Directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounts Standard and Applicable Law).

Under company law the Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of the profit or loss of the charitable company for that period. In preparing these financial statements the Directors are required to:

The Directors are responsible for keeping accounting records that disclose with reasonable accuracy the financial position of the charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

This report was approved by the Board on 19 April 2023 and signed on its behalf by

Jan Mather Chair of the Board of Directors

Behçet’s Patients Centres Annual Report 2023

16

C. Statement of Financial Activities

STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 MARCH 2023

(Incorporating the income and expenditure account)

Note
INCOME AND ENDOWMENTS
Income from charitable activities
3
Bank interest receivable
Total Income and endowments
EXPENDITURE ON:
Charitable activities
4
Governance costs
5
Total Expenditure
NET INCOME/(EXPENDITURE)
Transfers between funds
6
Net Movement in Funds
RECONCILIATION OF FUNDS
Total funds brought forward from
previous year
Total funds carried forward
Unrestricted
Fund
Restricted
Funds
2
117 272
101
0
103
117 272
0
118 607
0
2 843
0
121 450
103
-4 178
-4 178
4 178
-4 075
0
50 834
0
46 759
0
Total
2022-23
117 274
101
117 375
118 607
2 843
121 450
Total
2021-22
113 028
15
113 043
105 849
2 765
108 614
-4 075 4 429
0 0
-4 075 4 429
50 834
46 759
46 405
50 834

Behçet’s Patients Centres Annual Report 2023

17

STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 MARCH 2022

(Incorporating the income and expenditure account)

Note
INCOME AND ENDOWMENTS
Income from charitable activities
3
Bank interest receivable
Total Income and endowments
EXPENDITURE ON:
Charitable activities
4
Governance costs
5
Total Expenditure
NET INCOME/(EXPENDITURE)
Transfers between funds
6
Net Movement in Funds
RECONCILIATION OF FUNDS
Total funds brought forward from
previous year
Total funds carried forward
Unrestricted
Fund
Restricted
Funds
32
112 996
15
0
47
112 996
0
105 849
0
2 765
0
108 614
47
4 382
4 382
-4 382
4 429
0
46 405
0
50 834
0
Total
2021-22
113 028
15
113 043
105 849
2 765
108 614
Total
2020-21
108 620
33
108 653
99 486
2 378
101 864
4 429 6 789
0 0
4 429 6 789
46 405
50 834
39 616
46 405

Behçet’s Patients Centres Annual Report 2023

18

D. BALANCE SHEET AS AT 31 MARCH 2023

Notes
Current assets
Debtors
9
Prepayments
10
Cash at bank and in hand
11
Total current assets
Creditors: amounts falling due within
one year
12
Total assets less current liabilities
Creditors: amounts falling due after
one year
Net assets
Funds of the charity
Unrestricted fund
Restricted fund
Total funds
Unrestricted
Fund
Restricted
Funds
3
9 774
0
1 342
46 756
-4 460
46 759
6 656
0
6 656
46 759
0
0
0
46 759
0
46 759
0
0
0
46 759
0
Total
2022-23
9 777
1 342
42 296
53 415
6 656
46 759
0
46 759
46 759
0
46 759
Total
2021-22
5 946
1 267
47 051
54 264
3 430
50 834
0
50 834
50 834
0
50 834

All of the company’s activities were derived from continuing operations during the above two financial periods.

Note: Restricted Fund

This fund records monies received from NHS Commissioning via the London Strategic Health Authority and from Barts NHS Trust during this accounting period and the charitable purposes for which they have been employed.

The financial statements comply with the Charities Act 2011, the Companies Act 2006 and Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with FRS 102.

For the financial period ended 31 March 2023, the company was entitled to exemption from audit under section 477(1) of the Companies Act 2006, and no notice has been deposited under section 476(1) requesting an audit.

The directors acknowledge their responsibilities for:

These accounts have been prepared in accordance with the provisions applicable to companies subject to small companies’ regime.

Approved by the Board of Directors on 19 April 2023 and authorised for issue on 19 April 2023.

Jan Mather

Chair of the Board of Directors

Behçet’s Patients Centres Annual Report 2023

19

E. NOTES TO THE FINANCIAL STATEMENTS

PERIOD ENDED 31 MARCH 2023

1. CHARITY DETAILS

The charity is a charitable company limited by guarantee.

Its registered office is: 23-38 Hythe Bridge Street OXFORD OX1 2EP

The charity is a public benefit entity.

2. ACCOUNTING POLICIES

The principal accounting policies of the company are as follows:

(a) Basis of accounting

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with FRS 102 and the Companies Act 2006. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy note(s).

(b) Income

Grants from National Health Service England and receipts from Barts Health NHS Trust are included in the income and expenditure account as they become available.

(c) Explanation of the categories of expenditure

Charitable activities

This comprises all direct costs and management overheads which have been incurred by the charity in meeting its charitable objects.

Governance costs

Governance expenses represents the costs incurred in connection with the administration of the charity in compliance with constitutional and statutory requirements.

(d) Taxation

The company is a registered charity and is not liable to United Kingdom taxes on its income.

(e) Presentation currency

The financial statements are presented in Sterling, which is the functional currency of the charity.

(f) Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

(g) Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the charitable company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognized at the transaction price.

Behçet’s Patients Centres Annual Report 2023

20

3. ANALYSIS OF CHARITABLE INCOME

3.
ANALYSIS OF CHARITABLE INCOME
NHS England
Barts Health NHS Trust
Other donations
4.
ANALYSIS OF CHARITABLE EXPENDITURE
Staff training and HR costs
Salaries and wages (4 employees in 2023, 4 in 2022)
Employer’s NI
Employment rebate
Employer’s pension costs
General travel expenses
Subsistence costs
Insurance
Telephone/fax/email
Printing/photocopying
Newsletter
Postage
Stationery and materials
ICT software
Conference expenses

5.
ANALYSIS OF GOVERNANCE COSTS
Independent examination of accounts
Financial administration
Bank charges
Professional fees
Data Protection registration
AGM expenses

Board meeting expenses *
2023
2022
£
£
102 480
98 728
14 792
14 268
___ 2
_32
117 274
113 028
2023
2022
£
£
382
0
103 779
94 667
9 752
8 182
-5 000
-4 000
2 649
2 246
1 227
434
127
0
926
817
1 147
705
329
43
2 048
1 814
58
62
37
154
786
725
360
0
118 607
105 849
2023
2022
£
£
720
690
1 447
1 455
72
96
507
489
35
35
0
0
62
0
2 843
2 765
2022
£
98 728
14 268
32
2022
£
98 728
14 268
32
2 765

6. TRANSFER OF FUNDS

Any unspent monies received from NHSE have been transferred to unrestricted funds as the directors may use these funds to promote the charitable object without restriction. The operating deficit in 2022-23 was funded from these reserves.

7. DIRECTORS’ EMOLUMENTS

The directors are not entitled to and did not receive any remuneration during the year. Travel and accommodation expenses incurred by the directors on behalf of the charity may be reimbursed. Expenses were claimed by one director totalling £62 in 2022-23 (none in 2021-22). There were no expenses paid to third parties on behalf of trustees.

8. EMPLOYEE EXPENSES

The total average monthly number of employees during the year was 4 (2022: 4). The company has a pension scheme for its employees. Contributions totalling £2649 were made during the year (£2246 in 2022). There were no redundancy or termination payments. No staff were paid £60 000 or more during the year (2022: none).

60 000 or more during the year (2022: none).
The numbers of employees whose remuneration for the year fell 2023 2022
within the following bands were:
£10 000 to £20 000 1 3
£20 001 to £30 000 2 0
£30 001 to £40 000 0 1
£40 001 to £50 000 1 0

Behçet’s Patients Centres Annual Report 2023

21

The total paid to key management personnel, including pension contributions, was £ 18.2k (2022: £16.1k).

9.
ANALYSIS OF DEBTORS
Donations due from PayPal
NHS England
Barts Health NHS Trust

10.
ANALYSIS OF PREPAYMENTS
Insurance premium paid in advance
Proportion of company secretarial fees paid in advance
11.
ANALYSIS OF CASH
CAF Bank current account
Scottish Widows 90-day account
Floats held by support Coordinators to meet expenses



12.
ANALYSIS OF CREDITORS (due within one year)
HMRC – PAYE and National Insurance payments
Pension scheme payments
Staff expenses claims
Provision for cost of independent examination of accounts

Behçet’s UK re-charges
2023
2022
£
£
3
1
8 540
0
1 234
5 945
9 777
5 946
2023
2022
£
£
942
893
400
374
1 342
1 267
2023
2022
£
£
11 184
16 014
30 537
30 462
575
575
_
___
42 296 47 051
2023
2022
£
£
4 543
2 197
952
437
313
106
720
690
128
0
_

___
6 656
3 430

13. RELATED PARTY TRANSACTIONS

There were no related party transactions in either period and there were no donated services.

Behçet’s Patients Centres Annual Report 2023

22

F. INDEPENDENT EXAMINER'S REPORT

TO THE TRUSTEES OF

BEHÇET'S PATIENTS CENTRES

I report to the charity trustees on my examination of the accounts of Behçet's Patients Centres (the Company) for the year ended 31 March 2023, which are set out on pages 17 to 22.

Responsibilities and basis of report

As the charity's trustees of the company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under section 145 of the Charities Act 2011 (the '2011 Act). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent examiner's report

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Name of examiner: Caroline Webster

Name of firm: UHY Ross Brooke

Relevant professional body: Institute of Chartered Accountants in England and Wales

Address: Suite I, Windrush Court, Abingdon Business Park, ABINGDON, OX14 1SY

Signed:

Date: 9 May 2023

Behçet’s Patients Centres Annual Report 2023

23